NextCure, Inc. (NXTC) stock

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$6.40+0.17 (+2.73%)

Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%

NextCure gross margin

Gross margin is gross profit as a percentage of revenue.

NextCure has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?